Article Introducing Our Paper Published in the September 2022 Issue of Yodosha's Jikken Igaku
An article introducing our joint research paper with RIKEN, Robotic search for optimal cell culture in regenerative medicine, published in June, will appear in the September 2022 issue of Yodosha’s Jikken Igaku (on sale August 23).
Jikken Igaku September 2022 Issue — News & Hot Paper DIGEST
Is the future where AI and robots say “Leave the condition optimization to us” just around the corner?
Tsuki Kato, Genki Kanda
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.